A Pilot Cross-over Bioequivalence Study of E3810 for Healthy Japanese Male (Under Postprandial Condition).
Phase of Trial: Phase I
Latest Information Update: 20 May 2016
At a glance
- Drugs Rabeprazole (Primary)
- Indications Duodenal ulcer; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer; Zollinger-Ellison syndrome
- Focus Pharmacokinetics
- Sponsors Eisai Co Ltd
- 21 Sep 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 17 Mar 2010 New trial record